These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Susceptibility weighted imaging at 1.5 Tesla magnetic resonance imaging in dogs: Comparison with T2*-weighted gradient echo sequence and its clinical indications. Weston P; Morales C; Dunning M; Parry A; Carrera I Vet Radiol Ultrasound; 2020 Sep; 61(5):566-576. PubMed ID: 32663373 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility-weighted imaging: a major addition to the neuroimaging toolbox. Robinson R; Bhuta S J Neuroimaging; 2011 Oct; 21(4):309. PubMed ID: 20977532 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility-weighted imaging in the differential diagnosis of autoimmune central nervous system vasculitis and multiple sclerosis. Huang X; Lu T; Guo Z; Wei L; Chen S; Qiu W; Lu Z Mult Scler Relat Disord; 2019 Aug; 33():70-74. PubMed ID: 31158805 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility-weighted imaging: current status and future directions. Liu S; Buch S; Chen Y; Choi HS; Dai Y; Habib C; Hu J; Jung JY; Luo Y; Utriainen D; Wang M; Wu D; Xia S; Haacke EM NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192086 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic imaging of hemangiomas in the brain]. Toyoda K; Oba H Brain Nerve; 2011 Jan; 63(1):5-15. PubMed ID: 21228443 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance susceptibility weighted imaging in neurosurgery: current applications and future perspectives. Di Ieva A; Lam T; Alcaide-Leon P; Bharatha A; Montanera W; Cusimano MD J Neurosurg; 2015 Dec; 123(6):1463-75. PubMed ID: 26207600 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility-weighted imaging of the brain: current utility and potential applications. Robinson RJ; Bhuta S J Neuroimaging; 2011 Oct; 21(4):e189-204. PubMed ID: 21281380 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility artifact morphology is more conspicuous on susceptibility-weighted imaging compared to T2* gradient echo sequences in the brains of dogs and cats with suspected intracranial disease. La Rosa C; Donato PD; Specchi S; Bernardini M Vet Radiol Ultrasound; 2023 May; 64(3):464-472. PubMed ID: 36633010 [TBL] [Abstract][Full Text] [Related]
18. Role of a modified ultrafast MRI brain protocol in clinical paediatric neuroimaging. Ahamed SH; Lee KJ; Tang PH Clin Radiol; 2020 Dec; 75(12):914-920. PubMed ID: 32782127 [TBL] [Abstract][Full Text] [Related]
19. SWI or T2*: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska Imaging Dementia Study. Shams S; Martola J; Cavallin L; Granberg T; Shams M; Aspelin P; Wahlund LO; Kristoffersen-Wiberg M AJNR Am J Neuroradiol; 2015 Jun; 36(6):1089-95. PubMed ID: 25698623 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T. Kang H; Jang S Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]